HSBC Holdings’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.2K Sell
24,739
-35,724
-59% -$26.2K ﹤0.01% 2504
2025
Q1
$40.3K Sell
60,463
-3,091
-5% -$2.06K ﹤0.01% 2472
2024
Q4
$116K Sell
63,554
-18,111
-22% -$33.1K ﹤0.01% 2439
2024
Q3
$285K Buy
81,665
+20,807
+34% +$72.6K ﹤0.01% 2018
2024
Q2
$173K Buy
60,858
+5,404
+10% +$15.4K ﹤0.01% 2250
2024
Q1
$313K Buy
55,454
+3,055
+6% +$17.3K ﹤0.01% 2022
2023
Q4
$223K Buy
52,399
+24,628
+89% +$105K ﹤0.01% 1960
2023
Q3
$97.6K Buy
+27,771
New +$97.6K ﹤0.01% 2054
2023
Q2
Sell
-19,410
Closed -$87.5K 2248
2023
Q1
$87.5K Buy
19,410
+1,452
+8% +$6.55K ﹤0.01% 2087
2022
Q4
$139K Buy
17,958
+3,824
+27% +$29.7K ﹤0.01% 2372
2022
Q3
$79K Buy
14,134
+1,577
+13% +$8.81K ﹤0.01% 2324
2022
Q2
$66K Buy
+12,557
New +$66K ﹤0.01% 2666
2020
Q4
Sell
-16,143
Closed -$165K 2632
2020
Q3
$165K Buy
+16,143
New +$165K ﹤0.01% 2084
2019
Q4
Sell
-17,960
Closed -$163K 2537
2019
Q3
$163K Buy
+17,960
New +$163K ﹤0.01% 2317